Daily Physical Activity and Symptom Reporting in Breast Cancer Patients Undergoing Chemotherapy: An Intensive Longitudinal Examination.
Journal
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
04
05
2020
revised:
11
08
2020
accepted:
24
09
2020
pubmed:
1
10
2020
medline:
22
12
2021
entrez:
30
9
2020
Statut:
ppublish
Résumé
Increased activity is beneficial during chemotherapy, but treatment-related symptoms may be a barrier. This study examines the relationship between daily fluctuations in symptoms and activity during chemotherapy. Women undergoing chemotherapy for breast cancer [ For MVPA and LPA, within-person associations were statistically significant for same day affect, fatigue, pain, walking, activities of daily living (ADL) physical function, and cognitive function. Previous day anxiety was associated with next day LPA. Every one point worse symptom rating than an individual's overall average was associated with: (i) between 1.49 (pain) and 4.94 (fatigue) minutes less MVPA and between 4.48 (pain) and 24.72 (ADL physical function) minutes less LPA that day, and (ii) 11.28 minutes less LPA the next day. No between-person effects were significant for MVPA or LPA. Daily within-person variations in symptoms were associated with MVPA and LPA during chemotherapy for breast cancer. Future work should explore relationships between symptoms and activity further and identify whether tailoring to symptoms enhances efficacy of physical activity promotion interventions during chemotherapy.
Sections du résumé
BACKGROUND
Increased activity is beneficial during chemotherapy, but treatment-related symptoms may be a barrier. This study examines the relationship between daily fluctuations in symptoms and activity during chemotherapy.
METHODS
Women undergoing chemotherapy for breast cancer [
RESULTS
For MVPA and LPA, within-person associations were statistically significant for same day affect, fatigue, pain, walking, activities of daily living (ADL) physical function, and cognitive function. Previous day anxiety was associated with next day LPA. Every one point worse symptom rating than an individual's overall average was associated with: (i) between 1.49 (pain) and 4.94 (fatigue) minutes less MVPA and between 4.48 (pain) and 24.72 (ADL physical function) minutes less LPA that day, and (ii) 11.28 minutes less LPA the next day. No between-person effects were significant for MVPA or LPA.
CONCLUSIONS
Daily within-person variations in symptoms were associated with MVPA and LPA during chemotherapy for breast cancer.
IMPACT
Future work should explore relationships between symptoms and activity further and identify whether tailoring to symptoms enhances efficacy of physical activity promotion interventions during chemotherapy.
Identifiants
pubmed: 32994340
pii: 1055-9965.EPI-20-0659
doi: 10.1158/1055-9965.EPI-20-0659
pmc: PMC7710582
mid: NIHMS1634080
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2608-2616Subventions
Organisme : NCI NIH HHS
ID : K07 CA196840
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA193193
Pays : United States
Informations de copyright
©2020 American Association for Cancer Research.
Références
Qual Life Res. 2019 Dec;28(12):3333-3346
pubmed: 31493269
Med Sci Sports Exerc. 2008 Jan;40(1):181-8
pubmed: 18091006
Med Sci Sports Exerc. 2014 Sep;46(9):1744-51
pubmed: 24633595
J Clin Oncol. 2005 Aug 20;23(24):5814-30
pubmed: 16043830
Can Oncol Nurs J. 2015 Winter;25(1):37-48
pubmed: 26642493
Annu Rev Psychol. 2011;62:583-619
pubmed: 19575624
Acta Oncol. 2015 May;54(5):635-54
pubmed: 25752971
J Clin Oncol. 2015 Jun 10;33(17):1918-27
pubmed: 25918291
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2572-8
pubmed: 18086760
Cancer. 2017 Jul 15;123(14):2773-2780
pubmed: 28272835
Psychooncology. 2014 Nov;23(11):1220-8
pubmed: 24706506
BMC Public Health. 2014 Feb 15;14:168
pubmed: 24528783
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S471-80
pubmed: 10993417
Ann Epidemiol. 2014 Nov;24(11):837-42
pubmed: 25174285
Cochrane Database Syst Rev. 2016 Sep 21;9:CD005001
pubmed: 27650122
Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1324-30
pubmed: 24753546
Br J Sports Med. 2016 Mar;50(6):339-45
pubmed: 26385207
Stat Med. 2012 Nov 30;31(27):3328-36
pubmed: 22419604
Eur J Cancer. 2012 Feb;48(3):297-304
pubmed: 21920730
Cancer. 2003 Apr 1;97(7):1746-57
pubmed: 12655532
Int J Behav Nutr Phys Act. 2019 Aug 16;16(1):66
pubmed: 31420000
Biomed Res Int. 2014;2014:915172
pubmed: 25126580
Support Care Cancer. 2020 Apr;28(4):1919-1928
pubmed: 31367917
Breast. 2018 Aug;40:23-28
pubmed: 29674221
Obesity (Silver Spring). 2007 Apr;15(4):918-28
pubmed: 17426327
J Cancer Surviv. 2010 Jun;4(2):119-27
pubmed: 20180037
Eur J Oncol Nurs. 2014 Apr;18(2):132-9
pubmed: 24485013
Med Sci Sports Exerc. 1998 May;30(5):777-81
pubmed: 9588623
Transl Behav Med. 2020 Oct 8;10(4):1031-1038
pubmed: 31141593
Eur J Cancer Care (Engl). 2019 May;28(3):e13095
pubmed: 31090160
J Behav Med. 2004 Oct;27(5):425-44
pubmed: 15675633
Psychooncology. 2009 Apr;18(4):377-86
pubmed: 19241490
Med Sci Sports Exerc. 2008 Jun;40(6):1180-7
pubmed: 18460985
Patient Educ Couns. 2016 Jul;99(7):1220-1226
pubmed: 26860549
Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):430-8
pubmed: 17372237
Breast Cancer Res Treat. 2010 Sep;123(2):417-25
pubmed: 20582717
Assessment. 2011 Sep;18(3):263-83
pubmed: 21697139
Med Care. 2003 May;41(5):582-92
pubmed: 12719681
J Clin Oncol. 2007 Nov 10;25(32):5106-12
pubmed: 17991929
Support Care Cancer. 2010 Dec;18(12):1539-44
pubmed: 19956982
J Behav Med. 2006 Oct;29(5):461-75
pubmed: 16705484
Breast Cancer Res Treat. 2012 Jan;131(2):679-90
pubmed: 21953007
Med Sci Sports Exerc. 2011 Aug;43(8):1561-7
pubmed: 21233777
Med Oncol. 2011 Sep;28(3):753-65
pubmed: 20411366